148 related articles for article (PubMed ID: 19710594)
1. Impact of novel TRIM5alpha variants, Gly110Arg and G176del, on the anti-HIV-1 activity and the susceptibility to HIV-1 infection.
Nakajima T; Nakayama EE; Kaur G; Terunuma H; Mimaya JI; Ohtani H; Mehra N; Shioda T; Kimura A
AIDS; 2009 Oct; 23(16):2091-100. PubMed ID: 19710594
[TBL] [Abstract][Full Text] [Related]
2. Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection.
Speelmon EC; Livingston-Rosanoff D; Li SS; Vu Q; Bui J; Geraghty DE; Zhao LP; McElrath MJ
J Virol; 2006 Mar; 80(5):2463-71. PubMed ID: 16474153
[TBL] [Abstract][Full Text] [Related]
3. Role of common human TRIM5alpha variants in HIV-1 disease progression.
Goldschmidt V; Bleiber G; May M; Martinez R; Ortiz M; Telenti A;
Retrovirology; 2006 Aug; 3():54. PubMed ID: 16925802
[TBL] [Abstract][Full Text] [Related]
4. A naturally occurring single amino acid substitution in human TRIM5α linker region affects its anti-HIV type 1 activity and susceptibility to HIV type 1 infection.
Nakayama EE; Nakajima T; Kaur G; Mimaya JI; Terunuma H; Mehra N; Kimura A; Shioda T
AIDS Res Hum Retroviruses; 2013 Jun; 29(6):919-24. PubMed ID: 23379364
[TBL] [Abstract][Full Text] [Related]
5. Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection.
Javanbakht H; An P; Gold B; Petersen DC; O'Huigin C; Nelson GW; O'Brien SJ; Kirk GD; Detels R; Buchbinder S; Donfield S; Shulenin S; Song B; Perron MJ; Stremlau M; Sodroski J; Dean M; Winkler C
Virology; 2006 Oct; 354(1):15-27. PubMed ID: 16887163
[TBL] [Abstract][Full Text] [Related]
6. A TRIM5alpha exon 2 polymorphism is associated with protection from HIV-1 infection in the Pumwani sex worker cohort.
Price H; Lacap P; Tuff J; Wachihi C; Kimani J; Ball TB; Luo M; Plummer FA
AIDS; 2010 Jul; 24(12):1813-21. PubMed ID: 20588169
[TBL] [Abstract][Full Text] [Related]
7. The effect of TRIM5 variants on the susceptibility to HIV-1 infection and disease progression in the Polish population.
Bratosiewicz-Wąsik J; Miklasińska-Majdanik M; Wąsik TJ
Ann Hum Genet; 2024 Mar; 88(2):154-170. PubMed ID: 37942942
[TBL] [Abstract][Full Text] [Related]
8. An HIV-1 resistance polymorphism in TRIM5α gene among Chinese intravenous drug users.
Liu FL; Qiu YQ; Li H; Kuang YQ; Tang X; Cao G; Tang NL; Zheng YT
J Acquir Immune Defic Syndr; 2011 Apr; 56(4):306-11. PubMed ID: 21107267
[TBL] [Abstract][Full Text] [Related]
9. The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.
van Manen D; Rits MA; Beugeling C; van Dort K; Schuitemaker H; Kootstra NA
PLoS Pathog; 2008 Feb; 4(2):e18. PubMed ID: 18248091
[TBL] [Abstract][Full Text] [Related]
10. TRIM5 gene polymorphisms in HIV-1-infected patients and healthy controls from Northeastern Brazil.
Celerino da Silva R; Coelho AV; Arraes LC; Brandão LA; Crovella S; Guimarães RL
Immunol Res; 2016 Dec; 64(5-6):1237-1242. PubMed ID: 27388872
[TBL] [Abstract][Full Text] [Related]
11. Defects in assembly explain reduced antiviral activity of the G249D polymorphism in human TRIM5α.
Kömürlü S; Bradley M; Smolin N; Imam S; Pauszek RF; Robia SL; Millar D; Nakayama EE; Shioda T; Campbell EM
PLoS One; 2019; 14(3):e0212888. PubMed ID: 30889178
[TBL] [Abstract][Full Text] [Related]
12. Impact of cellular restriction gene (TRIM5α, BST-2) polymorphisms on the acquisition of HIV-1 and disease progression.
Singh H; Samani D; Ghate MV; Gangakhedkar RR
J Gene Med; 2018 Feb; 20(2-3):e3004. PubMed ID: 29282802
[TBL] [Abstract][Full Text] [Related]
13. Wild type and H43Y variant of human TRIM5alpha show similar anti-human immunodeficiency virus type 1 activity both in vivo and in vitro.
Nakayama EE; Carpentier W; Costagliola D; Shioda T; Iwamoto A; Debre P; Yoshimura K; Autran B; Matsushita S; Theodorou I
Immunogenetics; 2007 Jun; 59(6):511-5. PubMed ID: 17406861
[TBL] [Abstract][Full Text] [Related]
14. Variations in Trim5α and Cyclophilin A genes among HIV-1 elite controllers and non controllers in Uganda: a laboratory-based cross-sectional study.
Amanya SB; Nyiro B; Waswa F; Obura B; Nakaziba R; Nabulime E; Katabazi AF; Nabatanzi R; Bayiyana A; Mboowa G; Kayongo A; Wayengera M; Sande OJ
Retrovirology; 2020 Jul; 17(1):19. PubMed ID: 32631377
[TBL] [Abstract][Full Text] [Related]
15. TRIM5α H43Y Polymorphism and Susceptibility to HIV-1 Infection: A Meta-Analysis.
Deng J; Chen Y; Ding D; Lu P; Yang X; Song Z; Zhu H
AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1213-8. PubMed ID: 26398573
[TBL] [Abstract][Full Text] [Related]
16. TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment.
Singh R; Patel V; Mureithi MW; Naranbhai V; Ramsuran D; Tulsi S; Hiramen K; Werner L; Mlisana K; Altfeld M; Luban J; Kasprowicz V; Dheda K; Abdool Karim SS; Ndung'u T
J Virol; 2014 Apr; 88(8):4291-303. PubMed ID: 24478420
[TBL] [Abstract][Full Text] [Related]
17. A rare null allele potentially encoding a dominant-negative TRIM5alpha protein in Baka pygmies.
Torimiro JN; Javanbakht H; Diaz-Griffero F; Kim J; Carr JK; Carrington M; Sawitzke J; Burke DS; Wolfe ND; Dean M; Sodroski J
Virology; 2009 Aug; 391(1):140-7. PubMed ID: 19577266
[TBL] [Abstract][Full Text] [Related]
18. Immunoproteasome activation enables human TRIM5α restriction of HIV-1.
Jimenez-Guardeño JM; Apolonia L; Betancor G; Malim MH
Nat Microbiol; 2019 Jun; 4(6):933-940. PubMed ID: 30886358
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis of LEDGF/p75, APOBEC3G, TRIM5alpha, and tetherin in a Senegalese cohort of HIV-1-exposed seronegative individuals.
Mous K; Jennes W; Camara M; Seydi M; Daneau G; Mboup S; Kestens L; Van Ostade X
PLoS One; 2012; 7(3):e33934. PubMed ID: 22479480
[TBL] [Abstract][Full Text] [Related]
20. The V86M mutation in HIV-1 capsid confers resistance to TRIM5α by abrogation of cyclophilin A-dependent restriction and enhancement of viral nuclear import.
Veillette M; Bichel K; Pawlica P; Freund SM; Plourde MB; Pham QT; Reyes-Moreno C; James LC; Berthoux L
Retrovirology; 2013 Feb; 10():25. PubMed ID: 23448277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
